Cited by 753Liver Disease Diagnosis and TreatmentMitochondrial Function and PathologyDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 346 of the 348 references it cites were found in a registry or an index.

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Begriche, Karima, Igoudjil, Anissa, Pessayre, Dominique, Fromenty, Bernard·2006·Mitochondrion

DOI 10.1016/j.mito.2005.10.004

Open this paper in CoChat — free account

Abstract

Calorie-enriched diet and lack of exercise are causing a worldwide surge of obesity, insulin resistance and lipid accretion in liver (i.e. hepatic steatosis), which can lead to steatohepatitis. Steatosis and nonalcoholic steatohepatitis (NASH) can also be induced by drugs such as amiodarone, tamoxifen and some antiretroviral drugs, including stavudine and zidovudine. There is accumulating evidence that mitochondrial dysfunction (more particularly respiratory chain deficiency) plays a key role in the physiopathology of NASH whatever its initial cause. In contrast, the mitochondrial beta-oxidation of fatty acids can be either increased (as in insulin resistance-associated NASH) or decreased (as in drug-induced NASH). However, in both circumstances, generation of reactive oxygen species (ROS) by the damaged respiratory chain can be augmented. ROS generation in an environment enriched in lipids in turn induces lipid peroxidation which releases highly reactive aldehydic derivatives (e.g. malondialdehyde) that have diverse detrimental effects on hepatocytes and other hepatic cells. In hepatocytes, ROS, reactive nitrogen species and lipid peroxidation products further impair the respiratory chain, either directly or indirectly through oxidative damage to the mitochondrial genome. This consequently leads to the generation of more ROS and a vicious cycle occurs. Mitochondrial dysfunction can also lead to apoptosis or necrosis depending on the energy status of the cell. ROS and lipid peroxidation products also increase the generation of several cytokines (TNF-alpha, TGF-beta, Fas ligand) playing a key role in cell death, inflammation and fibrosis. Recent investigations have shown that some genetic polymorphisms can significantly increase the risk of steatohepatitis and that several drugs can prevent or even reverse NASH. Interestingly, most of these drugs could exert their beneficial effects by improving directly or indirectly mitochondrial function in liver. Finding a drug, which could fully prevent oxidative stress and mitochondrial dysfunction in NASH is a major challenge for the next decade.

Integrity signals

Registry

Crossref · 10.1016/j.mito.2005.10.004

Cites

346 of 346 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
Retracted
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
The metabolic syndrome
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
The metabolic syndrome
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Obesity as a medical problem
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844

Show all 348 references

Research works printed but not linked: 6

Abbey-Toby, 2005, β-Aminoisobutyric acid alleviates steatohepatitis in a murine model of diabetes and obesity, Virchows Arch., 447, 305
Begriche, 2005, A thymine catabolite, β-aminoisobutyric acid, reduces hepatic dysfunction and metabolic disorders in overweight or obese mice, J. Hepatol., 42, 243
Fiorini, 2002, Primary non-function in steatotic livers is due to differential Toll-like expression and endotoxin sensitivity, Hepatology, 36, 198
Haque, 2002, Nonalcoholic steatohepatitis (NASH) is associated with hepatocyte mitochondrial DNA depletion, Hepatology, 36, 403
Igoudjil, 2005, Mitochondrial and metabolic disturbances induced by high dose of stavudine in mice are alleviated by coadministration of l-carnitine. Possible role of PPAR-α, J. Hepatol., 42, 247
Sutton, 2003, The Ala-9Val dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria, Pharmacogentics, 13, 145, 10.1097/00008571-200303000-00004 · DOI

Sorted by citations

Items 301–400 of 752

Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease
Gan, S. K., & Watts, G. F. (2008) · Clinical Science · doi:10.1042/cs20070461 · Cited by 43
Association between type two diabetes and non-alcoholic fatty liver disease in youth
Alisi, A., Manco, M., Panera, N., & Nobili, V. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31826-5 · Cited by 42
HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: A novel mechanism for NAFLD
Jin, X., Yang, Y., Chen, K., Lv, Z., Zheng, L., Liu, Y.-P., Chen, S., Yu, C., Jiang, X., Zhang, C., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.034 · Cited by 42
Lipoic Acid Prevents High-Fat Diet-Induced Hepatic Steatosis in Goto Kakizaki Rats by Reducing Oxidative Stress Through Nrf2 Activation
Sena, C. M., Cipriano, M. A., Botelho, M. F., & Seiça, R. M. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092706 · Cited by 41
Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases
Park, M. N., Rahman, M. A., Rahman, M. H., Kim, J. W., Choi, M. J., Kim, J. W., Choi, J., Moon, M., Ahmed, K. R., & Kim, B. (2022) · Antioxidants · doi:10.3390/antiox11102041 · Cited by 44
Metabolite Profiles Reveal Energy Failure and Impaired Beta-Oxidation in Liver of Mice with Complex III Deficiency Due to a BCS1L Mutation
Kotarsky, H., Keller, M., Davoudi, M., Levéen, P., Karikoski, R., Enot, D. P., & Fellman, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041156 · Cited by 42
In vitro antioxidant activity and inhibitory effect, on oleic acid-induced hepatic steatosis, of fractions and subfractions from oat (Avena sativa L.) ethanol extract
Cai, S., Huang, C. G., Ji, B., Zhou, F. L., Wise, M. L., Zhang, D., & Yang, P. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.07.017 · Cited by 41
Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium l-glutamate in rats
Lazarin, M. D. O., Ishii‐Iwamoto, E. L., Yamamoto, N. S., Constantin, R. P., Garcia, R. F., da Costa, C. E. M., Vitoriano, A. D. S., de Oliveira, M. C., & Salgueiro‐Pagadigorria, C. L. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.07.003 · Cited by 40
Acetyl-l-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease
Kathirvel, E., Morgan, K., French, S. W., & Morgan, T. R. M. (2013) · Nutrition Research · doi:10.1016/j.nutres.2013.08.001 · Cited by 39
Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats
Ezquerro, S., Becerril, S., Tuero, C., Méndez-Giménez, L., Mocha, F., Moncada, R., Valentí, V., Cienfuegos, J. A., Catalán, V., Gómez‐Ambrosi, J., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0420-2 · Cited by 42
Sagittaria sagittifolia polysaccharide interferes with arachidonic acid metabolism in non-alcoholic fatty liver disease mice via Nrf2/HO-1 signaling pathway
Deng, X., Ke, X., Tang, Y., Luo, W., Dong, R., Ge, D., Han, L., Yang, Y., Liu, H., Reyila, T., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110806 · Cited by 39
Mitochondrial and Immunoallergic Injury Increase Risk of Positive Drug Rechallenge After Drug-Induced Liver Injury
Hunt, C. M. (2010) · Hepatology · doi:10.1002/hep.24022 · Cited by 39
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
Ezrokhi, M., Luo, S., Trubitsyna, Y., & Cincotta, A. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-104 · Cited by 38
Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease
Mu, C., Wang, S., Wang, Z., Tan, J., Yin, H.-Z., Wang, Y., Dai, Z., Ding, D., & Yang, F. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101774 · Cited by 40
Diminished stress resistance and defective adaptive homeostasis in age-related diseases
Lomeli, N., Bota, D. A., & Davies, K. J. A. (2017) · Clinical Science · doi:10.1042/cs20160982 · Cited by 39
Dietary sea buckthorn polysaccharide reduced lipid accumulation, alleviated inflammation and oxidative stress, and normalized imbalance of intestinal microbiota that was induced by high-fat diet in zebrafish Danio rerio
Lan, Y., Wang, C., Zhang, C., Li, P., Zhang, J., Ji, H., & Yu, H. (2022) · Fish Physiology and Biochemistry · doi:10.1007/s10695-022-01105-0 · Cited by 38
Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner
Berardi, D. E., Bock-Hughes, A., Terry, A. R., Drake, L. E., Bozek, G., & Macleod, K. F. (2022) · Science Advances · doi:10.1126/sciadv.abo2510 · Cited by 37
Amelioration of nonalcoholic fatty liver disease by hepatic stimulator substance via preservation of carnitine palmitoyl transferase-1 activity
Xiao, W., Ren, M., Zhang, C., Li, S., & An, W. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00133.2014 · Cited by 38
Fatty liver disease in children: eat now pay later
Bruyne, R. D., Fitzpatrick, E., & Dhawan, A. K. (2010) · Hepatology International · doi:10.1007/s12072-009-9160-z · Cited by 37
In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine‐ and Choline‐Deficient Diet
Freitas, I., Boncompagni, E., Tarantola, E., Gruppi, C., Bertone, V., Ferrigno, A., Milanesi, G., Vaccarone, R., Tira, M. E., & Vairetti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9307064 · Cited by 37
Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease
Fontes, A., Pagès, M. A. I., Oliveira, P. J., Ramalho‐Santos, J., Zischka, H., & Azul, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163987 · Cited by 38
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
Michelotti, A., de Scordilli, M., Palmero, L., Guardascione, M., Masala, M., Roncato, R., Foltran, L., Ongaro, E., & Puglisi, F. (2021) · Cells · doi:10.3390/cells10082034 · Cited by 40
High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes
Igoudjil, A., Massart, J., Begriche, K., Descatoire, V., Robin, M., & Fromenty, B. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.01.011 · Cited by 37
The metabolism and function of phospholipids in Mitochondria
Dong, J., Ye, F., Lin, J., He, H., & Song, Z. (2022) · Mitochondrial Communications · doi:10.1016/j.mitoco.2022.10.002 · Cited by 41
Polystyrene microplastics induce hepatic lipid metabolism and energy disorder by upregulating the NR4A1-AMPK signaling pathway
Chiu, H., Chu, C.-W., Huang, C., Chia, Z., Wang, Y.-L., & Lee, Y. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.125850 · Cited by 37
Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis
Massart, J., Robin, M., Noury, F., Fautrel, A., Lettéron, P., Bado, A., Eliat, P., & Fromenty, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01580.x · Cited by 36
Immunosuppressant drug tacrolimus induced mitochondrial nephrotoxicity, modified PCNA and Bcl-2 expression attenuated by Ocimum basilicum L. in CD1 mice
Oyouni, A. A. A., Saggu, S., Tousson, E., & Rehman, H. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.06.003 · Cited by 39
Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases
Li, J., Wang, T., Xia, J., Yao, W., & Huang, F. (2019) · The FASEB Journal · doi:10.1096/fj.201901175r · Cited by 39
PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis
Jin, K., Liu, Y., Shi, Y., Zhang, H., Sun, Y., Zhangyuan, G., Wang, F., Yu, W., Wang, J., Tao, X., et al. (2020) · Theranostics · doi:10.7150/thno.42658 · Cited by 35
LncRNA GAS5 Knockdown Mitigates Hepatic Lipid Accumulation via Regulating MiR-26a-5p/PDE4B to Activate cAMP/CREB Pathway
Xu, S., Wang, Y., Li, Z., Hua, Q., Jiang, M., & Fan, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889858 · Cited by 38
Estrés oxidativo hepatocitario y hepatopatía alcohólica
de la Rosa, L. C., Moshage, H. J., & Nieto, N. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000300006 · Cited by 37
Impact of Antiretroviral Therapy on Growth, Body Composition and Metabolism in Pediatric HIV Patients
Kim, R. J., & Rutstein, R. M. (2010) · Pediatric Drugs · doi:10.2165/11532520-000000000-00000 · Cited by 37
Effects of β‐aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity
Begriche, K., Massart, J., & Fromenty, B. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00765.x · Cited by 36
Therapeutic strategies for liver diseases based on redox control systems
Lee, J., Kim, J., Lee, R., Lee, E., Choi, T. G., Lee, A. S., Yoon, Y., Park, G., Namgoong, J., Lee, S., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113764 · Cited by 37
Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet
Wang, S., Li, X., Ji, H., & Shen, L. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121110 · Cited by 35
Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice
Choi, Y., Abdelmegeed, M. A., & Song, B. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.08.013 · Cited by 35
Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
Abenavoli, L., Procopio, A. C., Paravati, M. R., Costa, G., Milić, N., Alcaro, S., & Luzza, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123477 · Cited by 37
Indole-3-acetic acid improves the hepatic mitochondrial respiration defects by PGC1a up-regulation
Zhang, C., Fu, Q., Shao, K., Liu, L., Ma, X., Zhang, F., Zhang, X., Meng, L., Yan, C., & Zhao, X. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110442 · Cited by 36
Highly Purified Eicosapentaenoic Acid Ethyl Ester Prevents Development of Steatosis and Hepatic Fibrosis in Rats
Kajikawa, S., Harada, T., Kawashima, A., Imada, K., & Mizuguchi, K. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1020-0 · Cited by 35
Expression of mitochondria-related genes is elevated in overfeeding-induced goose fatty liver
Osman, R. H., Shao, D., Liu, L., Xia, L., Sun, X., Zheng, Y., Wang, L., Zhang, R., Zhang, Y., Zhang, J., et al. (2015) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2015.11.006 · Cited by 35
Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice
Yamada, T., Obata, A., Kashiwagi, Y., Rokugawa, T., Matsushima, S., Hamada, T., Watabe, H., & Abe, K. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.03.009 · Cited by 35
Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease
Kwon, Y., Gottmann, P., Wang, S., Tissink, J. J., Motzler, K., Sekar, R., Albrecht, W., Cadenas, C., Hengstler, J. G., Schürmann, A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.040 · Cited by 38
Effect of carnitine‐orotate complex on glucose metabolism and fatty liver: A double‐blind, placebo‐controlled study
Hong, E. S., Kim, E. K., Kang, S. M., Khang, A. R., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. K. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12536 · Cited by 34
Pathways affected by 3,5-diiodo- l -thyronine in liver of high fat-fed rats: Evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry
Silvestri, E., Cioffi, F., Glinni, D., Ceccarelli, M., Lombardi, A., de Lange, P., Chambery, A., Severino, V., Lanni, A., Goglia, F., et al. (2010) · Molecular BioSystems · doi:10.1039/c0mb00040j · Cited by 34
Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver
El-Lakkany, N. M., el-Din, S. H. S., Sabra, A.-N. A., Hammam, O. A., & Ebeid, F. (2016) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.192487 · Cited by 34
The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)
Wang, Z., Li, S., Wang, R., Guo, L., Xu, D., Zhang, T., Xu, Y., Wang, W., Wang, M., Gan, Z., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00164-4 · Cited by 34
Preventive Effect of a Melon Extract Rich in Superoxide Scavenging Activity on Abdominal and Liver Fat and Adipokine Imbalance in High-Fat-Fed Hamsters
Décordé, K., Agne, A., Lacan, D., Ramos, J., Fouret, G., Ventura, E., Feillet‐Coudray, C., Cristol, J., & Rouanet, J. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900504g · Cited by 34
Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
Mignini, I., Galasso, L., Piccirilli, G., Calvez, V., Termite, F., Esposto, G., Borriello, R., Miele, L., Ainora, M. E., Gasbarrini, A., et al. (2024) · Antioxidants · doi:10.3390/antiox13121532 · Cited by 39
Modulation of hepatic redox status and mitochondrial metabolism by exercise: Therapeutic strategy for liver diseases
Ascensão, A. A. M. R., Martins, M. J., Alves, E. S., Gonçalves, I. O., Portincasa, P., Oliveira, P. J., & Magalhães, J. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.07.002 · Cited by 33
Peptides released from bovine α-lactalbumin by simulated digestion alleviated free fatty acids-induced lipid accumulation in HepG2 cells
Chen, H., Qi, X., Guan, K., Gu, Y., Wang, R., Li, Q., & Ma, Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104618 · Cited by 33
Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride
Ichikawa, K., Okabayashi, T., Shima, Y., Iiyama, T., Takezaki, Y., Munekage, M., Namikawa, T., Sugimoto, T., Kobayashi, M., Mimura, T., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1974-4 · Cited by 33
Microsomal triglyceride transfer protein and nonalcoholic fatty liver disease
Pereira, I. V. A., Stefano, J. T., & Oliveira, C. P. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.22 · Cited by 33
The indole derivative NecroX‐7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS / RNS and inflammation
Chung, H. K., Kim, Y. K., Park, J., Ryu, M. J., Chang, J. Y., Hwang, J. H., Lee, C., Kim, S., Kim, H. J., Kweon, G. R., et al. (2014) · Liver International · doi:10.1111/liv.12741 · Cited by 32
Urine metabolic fingerprinting can be used to predict the risk of metritis and highlight the pathobiology of the disease in dairy cows
Dervishi, E., Zhang, G., Hailemariam, D., Mandal, R., Wishart, D. S., & Ametaj, B. N. (2018) · Metabolomics · doi:10.1007/s11306-018-1379-z · Cited by 32
HWL‐088, a new potent free fatty acid receptor 1 (FFAR1) agonist, improves glucolipid metabolism and acts additively with metformin in ob/ob diabetic mice
Chen, Y., Ren, Q., Zhou, Z., Deng, L., Hu, L., Zhang, L., & Li, Z. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14980 · Cited by 31
Calcium supplementation relieves high-fat diet-induced liver steatosis by reducing energy metabolism and promoting lipolysis
Zhang, Z., Liu, S., Qi, Y., Aluo, Z., Zhang, L., Yu, L., Li, Q., Luo, Z., Sun, Z., Zhou, L., et al. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108645 · Cited by 32
Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD)
Valenzuela‐Vallejo, L., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155246 · Cited by 32
Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease
Tarantino, G., Marra, M., Contaldo, F., & Pasanisi, F. (2008) · Clinical and investigative medicine · doi:10.25011/cim.v31i1.3138 · Cited by 32
Aqueous Extract of Yerba Mate Tea Lowers Atherosclerotic Risk Factors in a Rat Hyperlipidemia Model
Gao, H., Liu, Z., Wan, W., Qu, X., & Chen, M. (2012) · Phytotherapy Research · doi:10.1002/ptr.4856 · Cited by 31
Protein glutathionylation increases in the liver of patients with non‐alcoholic fatty liver disease
Piemonte, F., Petrini, S., Gaeta, L. M., Tozzi, G., Bertini, E., Vito, R. D., Boldrini, R., Marcellini, M., Ciacco, E., & Nobili, V. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05070.x · Cited by 32
HIV and liver disease forum: Conference proceedings
Sherman, K. E., Peters, M. G., & Koziel, M. J. (2007) · Hepatology · doi:10.1002/hep.21722 · Cited by 32
Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction.
Wang, L., Lv, Y., Yao, H., Yin, L., & Shang, J. (2015) · PubMed Central · Cited by 31
Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
Pasqua, L. G. D., Cagna, M., Berardo, C., Vairetti, M., & Ferrigno, A. (2022) · Biomedicines · doi:10.3390/biomedicines10010194 · Cited by 33
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
Stefano, J. T., Pereira, I. V. A., Torres, M. M., Bida, P. M., Coelho, A. M. M., Xerfan, M. P., Cogliati, B., Barbeiro, D. F., Mazo, D. F. D. C., Kubrusly, M. S., et al. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143962 · Cited by 31
Lower adropin expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease
Chen, X., Sun, X., Shen, T., Chen, Q., Chen, S., Pang, J., Mi, J., Tang, Y., You, Y., Xu, H., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.005 · Cited by 30
The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics
Malladi, N., Alam, M. J., Maulik, S. K., & Banerjee, S. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106766 · Cited by 33
NASH may be trash: Table 1
Cassiman, D. M., & Jaeken, J. (2008) · Gut · doi:10.1136/gut.2007.123240 · Cited by 30
Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-β signaling
Cummins, T. D., Barati, M. T., Coventry, S. C., Salyer, S. A., Klein, J. B., & Powell, D. W. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.029 · Cited by 29
Effects of a high fat diet on liver mitochondria: increased ATP-sensitive K+ channel activity and reactive oxygen species generation
Cardoso, A. R., Cabral‐Costa, J. V., & Kowaltowski, A. J. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9284-9 · Cited by 31
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients
Tai, C., Huang, C., Tu, H., Hwang, J., Yeh, M., Huang, C., Huang, J., Dai, C., Chuang, W., & Yu, M. (2016) · Medicine · doi:10.1097/md.0000000000003120 · Cited by 29
Mystery of bisphenol F-induced nonalcoholic fatty liver disease-like changes: Roles of Drp1-mediated abnormal mitochondrial fission in lipid droplet deposition
Zhang, L., Xie, X., Tao, J., Wang, S., Hu, M., Wang, X., Yu, Z., Xu, L., Lin, Y., Wu, W., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.166831 · Cited by 28
A Western diet induced NAFLD in LDLR−− mice is associated with reduced hepatic glutathione synthesis
Li, L., Zhang, G., Lee, K., López, R., Previs, S. F., Willard, B. B., McCullough, A. J., & Kasumov, T. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.032 · Cited by 28
Sennoside A protects mitochondrial structure and function to improve high-fat diet-induced hepatic steatosis by targeting VDAC1
Le, J., Jia, W., & Sun, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.108 · Cited by 28
Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
Lee, H. J., & Yang, S. J. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.3 · Cited by 29
Rooibos tea (Aspalathus linearis) ameliorates the CCl4-induced injury to mitochondrial respiratory function and energy production in rat liver
Uličná, O., Vančová, O., Kucharská, J., Janega, P., & Waczulı́ková, I. (2019) · General Physiology and Biophysics · doi:10.4149/gpb_2018037 · Cited by 28
Holly (Ilex latifolia Thunb.) Polyphenols Extracts Alleviate Hepatic Damage by Regulating Ferroptosis Following Diquat Challenge in a Piglet Model
He, P., Hua, H., Tian, W., Zhu, H., Liu, Y., & Xu, X. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.604328 · Cited by 28
Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signaling
Xu, Q., Fan, Y., Loor, J. J., Liang, Y., Lv, H., Sun, X., Jia, H., & Xu, C. (2020) · Food & Function · doi:10.1039/d0fo02684k · Cited by 28
Hepatoprotective effects of sea cucumber ether-phospholipids against alcohol-induced lipid metabolic dysregulation and oxidative stress in mice
Wang, X., Wang, Y., Liu, Y., Cong, P., Xu, J., & Xue, C. (2022) · Food & Function · doi:10.1039/d1fo03833h · Cited by 28
Avocado oil alleviates non-alcoholic fatty liver disease by improving mitochondrial function, oxidative stress and inflammation in rats fed a high fat–High fructose diet
Garcia‐Berumen, C. I., Vargas-Vargas, M. A., Ortiz‐Avila, O., Piña–Zentella, R. M., Ramos‐Gómez, M., Figueroa–García, M. D. C., Mejía‐Zepeda, R., Rodríguez-Orozco, A. R., Saavedra‐Molina, A., & Cortés‐Rojo, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1089130 · Cited by 28
Lotus Seedpod Extracts Reduced Lipid Accumulation and Lipotoxicity in Hepatocytes
Liu, Y., Lai, Y., Lin, H., & Chen, J. (2019) · Nutrients · doi:10.3390/nu11122895 · Cited by 29
Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( MASLD ): How does the animal model resemble human disease?
Jakubek, P., Kalinowski, P., Karkucińska‐Więckowska, A., Kaikini, A. A., Simões, I. C. M., Potes, Y., Kruk, B., Grajkowska, W., Pinton, P., Milkiewicz, P., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302447r · Cited by 27
The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model
Tzeng, T., Tzeng, Y.-C., Cheng, Y.-J., Liou, S., & Liu, I.-M. (2015) · Nutrients · doi:10.3390/nu7105423 · Cited by 27
Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets
Strathearn, L. S., Stepanov, A. I., & Font-Burgada, J. (2020) · Nutrients · doi:10.3390/nu12040933 · Cited by 26
Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis
Gao, Y., Wang, Y., Liu, H., Liu, Z., & Zhao, J. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.03.021 · Cited by 26
Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)—A Review
Różański, G., Kujawski, S., Newton, J. L., Zalewski, P., & Słomko, J. (2021) · Nutrients · doi:10.3390/nu13082654 · Cited by 27
Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease?
Schnegelberger, R. D., Lang, A. L., Arteel, G. E., & Beier, J. I. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.002 · Cited by 27
A novel HSF1 activator ameliorates non‐alcoholic steatohepatitis by stimulating mitochondrial adaptive oxidation
Rao, Y., Li, C., Hu, Y., Xu, Y., Song, B., Guo, S., Jiang, Z., Zhao, D., Chen, S.-B., Tan, J., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15727 · Cited by 27
Proteomic analysis of liver mitochondria from rats with nonalcoholic steatohepatitis
Li, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4778 · Cited by 27
Label-Free Proteomics Assisted by Affinity Enrichment for Elucidating the Chemical Reactivity of the Liver Mitochondrial Proteome toward Adduction by the Lipid Electrophile 4-hydroxy-2-nonenal (HNE)
Tzeng, S., & Maier, C. S. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00002 · Cited by 27
High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model
Bubnov, R. V., Drahulian, M., Buchek, P. V., & Gulko, T. P. (2017) · The EPMA Journal · doi:10.1007/s13167-017-0115-5 · Cited by 28
Metabolic disorders and chronic viral disease: The case of HIV and HCV
Slama, L., Camus, C. H.-L., Serfaty, L., Pialoux, G., Capeau, J., & Gharakhanian, S. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.08.003 · Cited by 27
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression
Vouilloz, A., Bourgeois, T., Diedisheim, M., Pilot, T., Jalil, A., Guern, N. L., Bergas, V., Rohmer, N., Castelli, F. A., Leleu, D., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156051 · Cited by 27
Exercise mitigates diclofenac‐induced liver mitochondrial dysfunction
Alves, E. S., Marques‐Aleixo, I., Coxito, P. M., Balça, M. M., Rizo‐Roca, D., Rocha‐Rodrigues, S., Martins, S., Torrella, J. R., Oliveira, P. J., Moreno, A. J., et al. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12285 · Cited by 26
Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
Kim, S., Kang, O., Lee, Y., Han, S., Ahn, Y.-S., Cha, S.-W., Seo, Y., Kong, R., & Kwon, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147745 · Cited by 26
In vivo redox metabolic imaging of mitochondria assesses disease progression in non-alcoholic steatohepatitis
Nakata, R., Hyodo, F., Murata, M., Eto, H., Nakaji, T., Kawano, T., Narahara, S., Yasukawa, K., Akahoshi, T., Tomikawa, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17447-2 · Cited by 25
Fasting Status and Thermally Oxidized Sunflower Oil Ingestion Affect the Intestinal Antioxidant Enzyme Activity and Gene Expression of Male Wistar Rats
Olivero-David, R., Bastida, S., Schultz, A., González-Torres, L., González‐Muñoz, M. J., Sánchez-Muniz, F. J., & Benedı́, J. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903622q · Cited by 26
Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
Elbadawy, M., Tanabe, K., Yamamoto, H., Ishihara, Y., Mochizuki, M., Abugomaa, A., Yamawaki, H., Kaneda, M., Usui, T., & Sasaki, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1243258 · Cited by 26
Targeting Mitochondrial Dysfunction for the Prevention and Treatment of Metabolic Disease by Bioactive Food Components
Kim, M., Lee, J., & Lee, J. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.3.306 · Cited by 28
Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis
Zhu, S., Liao, L., Zhong, Y., Liu, Z., Lu, J., Yang, Z., Xiao, Y., & Xu, X. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.01.008 · Cited by 28
Multiparametric evaluation of the cytoprotective effect of the Mangifera indica L. stem bark extract and mangiferin in HepG2 cells
Tolosa, L., Rodeiro, I., Donato, M. T., Herrera, J., Delgado, R., Castell, J. V., & Gómez-Lechón, M. J. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12071 · Cited by 24

Authors: Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B.
Affiliations: Inserm (FR)
Corresponding author: Fromenty, Bernard
ORCID: Begriche, Karima
Fromenty, Bernard
Venue: Mitochondrion
Publisher: Elsevier BV
Published: 2006-02
Volume: 6
Issue: 1
Pages: 1-28
ISSN: 1567-7249 (ISSN-L)
DOI: 10.1016/j.mito.2005.10.004
OpenAlex: W1978045299
Cited by: 753
References: 348
Citations by year: 2026: 24 · 2025: 28 · 2024: 33 · 2023: 27 · 2022: 55 · 2021: 47 · 2020: 43 · 2019: 48 · 2018: 43 · 2017: 32 · 2016: 39 · 2015: 39 · 2014: 38 · 2013: 39 · 2012: 35
FWCI: 4.46
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Mitochondrion (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: mitochondrial dysfunction, nonalcoholic steatohepatitis, hepatic steatosis, respiratory chain deficiency, reactive oxygen species, lipid peroxidation, malondialdehyde, mitochondrial DNA damage, insulin resistance, drug-induced liver injury, fatty acid beta-oxidation, apoptosis, cytokines, liver fibrosis, genetic polymorphism, oxidative stress
MeSH terms: Animals, Drug Therapy, Fatty Liver, Hepatitis, Humans, Mitochondria, Liver, Mitochondrial Diseases, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks